Modal Title
Course Description
Recent political activity has precipitated an increased focus on medication abortion as an option for individuals seeking an abortion. This course will teach clinicians and other members of the healthcare workforce about the provision of medication abortion within their scope of practice. Content regarding safe and ethical practice, as well as updated knowledge about the medication abortion regulatory landscape, pharmacology and logistics of medication abortion prescribing and follow up, and medication abortion outcomes data will be presented.
Intended Audience
- Physician
- Physician Assistant
- Registered Nurse
- Advanced Practice Registered Nurses
- Pharmacist
- Pharmacy Technician
Learning Objectives
At the completion of this activity, healthcare providers will be able to:
- Identify terminology, global context, evolution of medication abortions over time in the U.S., and medication abortion safety and outcomes data
- Identify healthcare provider qualifications to prescribe medication abortion, legal requirements for dispensing in/out of healthcare setting, variations in state laws regulating medication abortion, and the FDA approval and monitoring of medication abortion
- Explain how to determine patient eligibility for medication abortion including gestational age, appropriate medication evaluation before medication abortion, and contraindications
- Identify medication abortion regimens including names, doses, mechanisms of action
- Describe how to counsel and manage patients including pain management, risks, side effects, post-medication abortion fertility, teratogenicity and ongoing pregnancy, and follow up
At the completion of this activity, assistants, aids, support staff, and pharmacy technicians will be able to:
- Identify what constitutes medication abortion
- Identify legally acceptable prescriptions for medication abortion
- Instructional Methods
-
- Assessment Review with Rationale
- Case Studies
- Take Home Resource
- Ungraded Self Assessment-Lesson Recall
- Video Narration
- Assessment
-
- Autograded and Quiz Retakes Allowed
- Daily CE Broker Reporting for Registered Boards
- Graded Final Quiz
- Passing 80%+
- Credit/Contact Hours
- 1
- Pharmacotherapy Hours
- 1
- Faculty
-
- Anne Cockerham, PhD, RN, CNM, WHNP-BC, CNE
Professor, Frontier Nursing University
- Anne Cockerham, PhD, RN, CNM, WHNP-BC, CNE
- Language
-
- English
- Release Date
- February 1, 2023
- Expiration Date
- February 1, 2026
- Arkansas State Board of Nursing
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Kansas State Board of Nursing
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Kentucky Board of Nursing
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Louisiana State Board of Medical Examiners
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Michigan Board of Nursing
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Michigan Board of Pharmacy
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Mississippi Board of Nursing
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Mississippi State Board of Medical Licensure
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- New Hampshire Medical Society
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- New Mexico Board of Nursing
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- New Mexico Certified Nurse Midwives and Licensed Midwives
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- New Mexico Medical Board
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Oklahoma Board of Medical Licensure and Supervision- Medical Doctors
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Oklahoma Board of Medical Licensure and Supervision- Physician Assistants
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- South Carolina Board of Medical Examiners
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- South Carolina Board of Nursing
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- State Medical Board of Ohio
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Tennessee Board of Medical Examiners
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Tennessee Board of Osteopathic Examination
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- West Virginia Board of Registered Nurses
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Wyoming Board of Nursing
-
- Provider ID
- 50-23363
- Course ID
- 20-990662
- Expiration Date
- N/A
- Accrediting CEs
-
Jointly provided by Partners for Advancing Clinical Education (PACE) and #1 Premiere Continuing Education.
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and #1 Premiere Continuing Education. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour(s).
Designated for 1 contact hour(s) of pharmacotherapy credit for Advance Practice Registered Nurses.Physician Continuing Education
PACE designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Continuing Education
PACE designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008073-9999-23-021-H01-P
Universal Activity Number - JA4008073-9999-23-021-H01-T
Type of Activity: ApplicationUpon successfully completing the post-test with a score of 80% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
- Instructions for CE Credit
-
Participation in this self-study activity should be completed in approximately 1 hour(s). To successfully complete this activity and receive CE credit, learners must follow these steps during the period from February 1, 2023 through February 1, 2026:
- Review objectives and disclosures
- Study the educational content
- Successfully complete activity assessment(s)
- Complete the activity evaluation
You must receive an assessment score of at least 80% and respond to all evaluation questions to receive a certificate.
- Disclosures
-
Disclosure of Conflicts of Interest
PACE requires planners, faculty, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Faculty: The faculty reported the following financial relationships or relationships to products or devices they have with ineligible companies:
-
Anne Cockerham, PhD, RN, CNM, WHNP-BC, CNE
Professor, Frontier Nursing University
• has no relevant financial relationships with ineligible companies to disclose
Planners & Managers & Translators: The PACE & #1 Premiere Continuing Education planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
-
Anne Cockerham, PhD, RN, CNM, WHNP-BC, CNE
